Adjust the setting of the site for easier reading.
Knowledge is power, and the more patients and the medical community know about specific gene mutations, the faster clinical trials for inherited retinal diseases (IRDs) may progress. Hear two experts explain the impact of testing for IRDs. #EyeWant2Know https://bit.ly/3oJSuci
Eye Want 2 Know is sponsored by Spark Therapeutics, Inc., a leader in the field of gene therapy research. On this site, the IRD community can stay informed about the importance of genetic testing and take action to learn more.
Visit aSharedVision.com for additional information about IRDs, retinal gene therapy research, and the importance of genetic testing.
1-855-SPARKTX
Disclaimer: Nothing on EyeWant2Know.com should be construed as medical advice or replace medical advice, medical visits, or recommendations from a health care professional. Patients should always consult with a doctor or other health care professional for medical advice.
A Shared Vision and its design and Eye Want 2 Know and its design are registered service marks of Spark Therapeutics in the United States. All other trademarks are property of their respective owners.
© 2021 Spark Therapeutics, Inc.
